Cambridge Investment Research Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $703K | Sell |
17,350
-5,800
| -25% | -$235K | ﹤0.01% | 2234 |
|
|
2025
Q1 | $1.19M | Sell |
23,150
-25
| -0.1% | -$1.28K | ﹤0.01% | 1723 |
|
|
2024
Q4 | $1.28M | Sell |
23,175
-1,900
| -8% | -$105K | ﹤0.01% | 1671 |
|
|
2024
Q3 | $825K | Buy |
25,075
+2,100
| +9% | +$69.1K | ﹤0.01% | 2009 |
|
|
2024
Q2 | $624K | Sell |
22,975
-1,675
| -7% | -$45.5K | ﹤0.01% | 2115 |
|
|
2024
Q1 | $896K | Buy |
24,650
+3,700
| +18% | +$134K | ﹤0.01% | 1805 |
|
|
2023
Q4 | $424K | Buy |
20,950
+200
| +1% | +$4.05K | ﹤0.01% | 2327 |
|
|
2023
Q3 | $369K | Buy |
+20,750
| New | +$369K | ﹤0.01% | 2339 |
|